Compounds > ezetimibe
Page last updated: 2024-09-04

ezetimibe and anacetrapib

ezetimibe has been researched along with anacetrapib in 4 studies

Compound Research Comparison

Studies
(ezetimibe)		Trials
(ezetimibe)		Recent Studies (post-2010)
(ezetimibe)		Studies
(anacetrapib)		Trials
(anacetrapib)		Recent Studies (post-2010) (anacetrapib)
2,4845631,46517933143

Protein Interaction Comparison

ProteinTaxonomyezetimibe (IC50)anacetrapib (IC50)
Cholesteryl ester transfer proteinHomo sapiens (human)0.0343

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ballantyne, CM; Catapano, AL; Norata, GD1
Akinsanya, KO; Castro-Perez, J; Chen, Y; Daniels, E; Johns, DG; Previs, SF; Roddy, TP; Wang, SP; Zhou, H1
Ashraf, TB; Ballantyne, CM; Cressman, MD; Gill, GG; Hunter, JA; Johnson-Levonas, AO; Kher, U; Mitchel, YB; Shah, S1
Adam, S; Durrington, PN; Soran, H1

Reviews

2 review(s) available for ezetimibe and anacetrapib

ArticleYear
New therapeutic principles in dyslipidaemia: focus on LDL and Lp(a) lowering drugs.
    European heart journal, 2013, Volume: 34, Issue:24

    Topics: Azetidines; Benzimidazoles; Benzodiazepines; Carrier Proteins; Cholesterol, LDL; Dicarboxylic Acids; Dyslipidemias; Ezetimibe; Fatty Acids; Humans; Hypolipidemic Agents; Lipoprotein(a); Oligonucleotides; Oxazolidinones; Proprotein Convertase 9; Proprotein Convertases; Serine Endopeptidases

2013
Optimising treatment of hyperlipidaemia: Quantitative evaluation of UK, USA and European guidelines taking account of both LDL cholesterol levels and cardiovascular disease risk.
    Atherosclerosis, 2018, Volume: 278

    Topics: Anticholesteremic Agents; Atorvastatin; Cardiology; Cardiovascular Diseases; Cholesterol, LDL; Europe; Ezetimibe; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Hyperlipidemias; Oxazolidinones; Practice Guidelines as Topic; Randomized Controlled Trials as Topic; Risk Factors; United Kingdom; United States

2018

Trials

1 trial(s) available for ezetimibe and anacetrapib

ArticleYear
Lipid-Modifying Efficacy and Tolerability of Anacetrapib Added to Ongoing Statin Therapy in Patients with Hypercholesterolemia or Low High-Density Lipoprotein Cholesterol.
    The American journal of cardiology, 2017, Feb-01, Volume: 119, Issue:3

    Topics: Aged; Anticholesteremic Agents; Cholesterol Ester Transfer Proteins; Cholesterol, HDL; Cholesterol, LDL; Double-Blind Method; Drug Therapy, Combination; Dyslipidemias; Ezetimibe; Female; Fibric Acids; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Male; Middle Aged; Niacin; Oxazolidinones; Treatment Outcome

2017

Other Studies

1 other study(ies) available for ezetimibe and anacetrapib

ArticleYear
In vivo effects of anacetrapib on preβ HDL: improvement in HDL remodeling without effects on cholesterol absorption.
    Journal of lipid research, 2013, Volume: 54, Issue:10

    Topics: Amides; Animals; Anticholesteremic Agents; Area Under Curve; Azetidines; Cholesterol; Cholesterol Ester Transfer Proteins; Cricetinae; Diet, High-Fat; Drug Evaluation, Preclinical; Dyslipidemias; Esters; Ezetimibe; High-Density Lipoproteins, Pre-beta; Humans; Intestinal Absorption; Male; Mesocricetus; Oxazolidinones; Sulfhydryl Compounds

2013